快而精医药 QGEN 深 沪
等待开盘 09-11 09:30:00 美东时间
42.13
-0.370
-0.87%
华盛通- 最 高42.625
- 今 开42.00
- 成交量 124.63万股
- 最 低 41.89
- 昨 收 42.50
- 总市值 869.96万
- 52周最高 57.465
- 市盈率 静 20.62
- 换手率 603.53%
- 52周最低 32.18
- 委 比 -88.06%
- 总股本 0.00亿
- 历史最高 60.0387
- 量 比 0.75
- 振 幅 1.73%
- 历史最低 7.4322
- 每 手 1
- 风险率 4.97%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 戴尔、Adobe获大行上调目标价；甲骨文绩前目标价遭调低
今日重点评级关注：富国银行：维持Pyxis Oncology"超配"评级，目标价从12美元升至19美元；Oppenheimer：维持Opus Genetics"跑赢大市"评级，目标价从10美元升至20美元
09-10 15:00
UBS Maintains Neutral on Qiagen, Lowers Price Target to $47
UBS analyst Dan Leonard maintains Qiagen (NYSE:QGEN) with a Neutral and lowers the price target from $52 to $47.
09-10 02:14
美股大行评级 | Take-Two、Csquare、Standard获多家大行首予买入评级！潜在涨幅215.32%！HC Wainwright.升Innate Pharma(IPHA)目标价至7美元
今日重点评级关注：HC Wainwright & Co.：维持Innate Pharma"买入"评级，目标价从5美元升至7美元；HC Wainwright & Co.：维持Immix Biopharma"买入"评级，目标价从20美元升至25美元
08-11 11:45
QIAGEN Says FDA Clears QIAstat-Dx BCID GPF Plus AMR Panel For Bloodstream Infections
QIAstat-Dx BCID GPF Plus AMR Panel detects 20 pathogen targets and 10 antimicrobial resistance markers from positive blood cultures in about one hour FDA clearance marks QIAGEN's entry into U.S. bloodstream infection testing and establishes the first member of a planned QIAstat-Dx BCID panel family ...
08-11 04:22
美股大行评级 | 花旗下调美光科技目标价从1400美元降至1150美元；爱彼迎、Datadog、Cloudflare、Etsy、Natera、拉夫劳伦获多家大行上调目标价
今日重点评级关注：康托·菲茨杰拉德：维持InflaRx"超配"评级，目标价从4美元升至6美元；RBC Capital：维持Nuvation Bio"跑赢大市"评级，目标价从19美元升至20美元
08-10 19:24
JP Morgan Maintains Overweight on Qiagen, Raises Price Target to $50
JP Morgan analyst Casey Woodring maintains Qiagen (NYSE:QGEN) with a Overweight and raises the price target from $45 to $50.
08-08 00:21
Conference Call: Qiagen Q3 Adj EPS expected to be more than $0.62 vs $0.64 Est; Sees Q3 Sales $538.330M-$543.660M vs $552.590M Est
Qiagen (NYSE:QGEN) Q3 expected to be more than $0.62 vs $0.64 Est. sees Q3 sales of $538.330 million-$543.660 million vs $552.590 million analyst estimate.
08-07 05:23
美股夜盘 | Voyager Technologies暴升14.96%，Palantir暴升13.72%
Voyager Technologies暴升14.96%；Palantir暴升13.72%；先进能源工业劲升10.33%
08-04 09:01
Qiagen Highlights Molecular Testing Solutions Supporting Response to Growing U.S. Cyclospora Outbreak; Says Qiagen’s FDA-Cleared QIAstat-Dx Gastrointestinal Panel 2 Can Detect Cyclospora Infections In About An Hour As Part Of A 16-Target Gastrointestinal Pathogens Menu
More than 1,600 U.S. cases of cyclosporiasis have been confirmed since May 2026 as infections linked to the foodborne parasite Cyclospora continue to rise nationwide QIAGEN’s FDA-cleared QIAstat-Dx Gastrointestinal Panel 2 can detect Cyclospora infections in about an hour as part of a 16-target gast...
07-16 04:09
Qiagen M&A Fever Builds: KKR, EQT, Advent Explore Possible Takeover
Qiagen NV (NYSE:QGEN) is drawing renewed investor attention after reports that several private equity firms are evaluating a potential takeover of the molecular diagnostics company. The stock surged 10.5% in the previous session on the takeover speculation, according to Benzinga Pro. Private Equity ...
07-10 21:26
